The present study indicates that the combined detection of miR‐29a and cystatin C distinguishes between T2DM patients and DN patients better than the detection of miR‐29a or cystatin C alone (p < 0.05, Figure 2). The gene discussed is CST3; the disease is type 2 diabetes mellitus.